Literature DB >> 6142899

Simultaneous measurement of tyrosine, tryptophan and related monoamines for determination of neurotransmitter turnover in discrete rat brain regions by liquid chromatography with electrochemical detection.

S M Lasley, I A Michaelson, R D Greenland, P M McGinnis.   

Abstract

Concomitant measurement of monoamine neurotransmitter turnover in discrete rat brain areas with the use of radiolabeled amino acid precursors permits simultaneous evaluation of interacting transmitter systems. [3H]Tyrosine and [3H]tryptophan were administered via indwelling catheters to unrestrained rats. Content and specific activity of norepinephrine, dopamine, 5-hydroxytryptamine, and the metabolites dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindoleacetic acid in addition to tyrosine and tryptophan were quantified by liquid chromatography with electrochemical detection and liquid scintillation counting. The method employs a simple extraction procedure without prior cleanup for chromatography. Neurotransmitter turnover rates that incorporated tyrosine- or tryptophan-specific activities were found to be two to four times greater than those that did not include them.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6142899     DOI: 10.1016/s0378-4347(00)83311-3

Source DB:  PubMed          Journal:  J Chromatogr


  12 in total

1.  Effect of 2-guanidinoethanol on levels of monoamines and their metabolites in the rat brain.

Authors:  I Yokoi; T Itoh; K Yufu; K Akiyama; M Satoh; S Murakami; H Kabuto; A Mori
Journal:  Neurochem Res       Date:  1991-10       Impact factor: 3.996

2.  The concentration of dopamine, 5-hydroxytryptamine, and some of their acid metabolites in the brain of genetically diabetic rats.

Authors:  R P Kwok; E K Walls; A V Juorio
Journal:  Neurochem Res       Date:  1985-05       Impact factor: 3.996

3.  Effects of an N-methyl-D-aspartate receptor agonist and its antagonist CPP on the levels of dopamine and serotonin metabolites in rat striatum collected in vivo by using a brain dialysis technique.

Authors:  H Kabuto; I Yokoi; K Mizukawa; A Mori
Journal:  Neurochem Res       Date:  1989-11       Impact factor: 3.996

4.  Influence of chronic inorganic lead exposure on regional dopamine and 5-hydroxytryptamine turnover in rat brain.

Authors:  S M Lasley; R D Greenland; D J Minnema; I A Michaelson
Journal:  Neurochem Res       Date:  1984-12       Impact factor: 3.996

5.  Comparison of the effects of bifemelane hydrochloride, idebenone and indeloxazine hydrochloride on ischemia-induced changes in brain monoamines and their metabolites in gerbils.

Authors:  K Haba; N Ogawa; M Asanuma; H Hirata; A Mori
Journal:  J Neural Transm Gen Sect       Date:  1992

6.  Acetyl-L-carnitine reduces impulsive behaviour in adolescent rats.

Authors:  Walter Adriani; Monica Rea; Marta Baviera; William Invernizzi; Mirjana Carli; Orlando Ghirardi; Antonio Caprioli; Giovanni Laviola
Journal:  Psychopharmacology (Berl)       Date:  2004-05-08       Impact factor: 4.530

7.  Effects of muscimol and baclofen on levels of monoamines and their metabolites in the El mouse brain.

Authors:  H Kabuto; I Yokoi; A Mori
Journal:  Neurochem Res       Date:  1988-12       Impact factor: 3.996

8.  2-Guanidinoethanol increased dopamine release and 3,4-dihydroxyphenylacetic acid content, but not homovanillic acid content in the rat brain: electroneurochemical and enzymological studies.

Authors:  I Yokoi; H Kabuto; K Hukuyama; Y Nishijima; T Itoh; K Yufu; K Akiyama; A Mori
Journal:  Neurochem Res       Date:  1992-07       Impact factor: 3.996

9.  Altered central monoamine response to D-amphetamine in rats chronically exposed to inorganic lead.

Authors:  S M Lasley; R D Greenland; D J Minnema; I A Michaelson
Journal:  Neurochem Res       Date:  1985-07       Impact factor: 3.996

10.  The effects of sho-saiko-to-go-keishi-ka-shakuyaku-to (TJ-960) on ischemia-induced changes of brain acetylcholine and monoamine levels in gerbils.

Authors:  K Haba; N Ogawa; A Mori
Journal:  Neurochem Res       Date:  1990-05       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.